DTAC in 2026: what NHS buyers assess
A professional guide to DTAC in England: its assessment scope, who reviews the evidence and why other assurance and local deployment checks still matter.
Healthcare Edition / Coverage
Policy & systems
The decisions shaping how healthcare is organised, funded and delivered.
Start with your question
Separate assessment, safety and authority
Begin with NHS digital-technology assessment in England, follow the manufacturer and deploying organisation’s different responsibilities, then examine the AMA’s US proposal for clinical AI authority. These documents answer different questions and belong to different jurisdictions.
Explore 3 articles
DCB0129 and DCB0160: who is responsible for what?
How DCB0129 assigns manufacturer responsibilities and DCB0160 covers local deployment, including safety evidence handover and later changes in England.
When AI can act in care, who gives it authority?
The AMA’s October framework separates capability, permission, oversight and responsibility. Its use of “licensure” is a proposal, not a new law.
Find your way through device oversight
Recognition, surveillance, public records and guidance priorities serve different purposes. These reports explain the relevant Great Britain, EU and US systems without treating their requirements as interchangeable.
Explore 4 articles
CE-marked medical devices: Great Britain’s plan for indefinite recognition
The government plans indefinite recognition for devices meeting EU MDR or IVDR rules. Legislative changes remain to come, while registration, UK representation and post-market duties continue.
Medical-device surveillance in Great Britain: PMSR, PSUR and vigilance explained
How MHRA guidance distinguishes routine PMSR and PSUR updates from serious-incident reporting in Great Britain, with report cycles, request deadlines and scope.
EUDAMED explained: modules, public records and rollout
What EUDAMED records, which modules became mandatory in May 2026, and what a public device or certificate entry can tell you.
FDA’s fiscal 2027 guidance priorities: AI devices and surgical robots
The FDA plans final guidance on AI device software and surgical robots, plus a draft on conversational AI for mental disorders. The priority list does not guarantee publication.
Policy & systems
GP website down: the service layers behind the Silicon Practice outage
NHS notices separate website hosting, online requests and clinical records. That distinction shapes the questions practice teams need to resolve during a supplier disruption.
Policy & systems
HTI-5 changes EHR certification on more than one timetable
The US final rule removes 14 certification criteria and revises seven. Official tables separate the changes due at the effective date from later transitions and unfinished proposals.
Policy & systems
Australia’s sunscreen reforms put the SPF evidence chain under scrutiny
The TGA plans changes to finished-product testing, laboratory oversight and ingredient quality. The October announcement begins further development rather than making every proposal a current requirement.
Policy & systems
What CDC’s new drug-resistance estimates actually count
The 2026 report estimates 9.7 million infections across its listed threats using mainly 2023 data. Changed methods, overlapping categories and C. difficile all matter when reading the total.
Policy & systems
Antibiotic use and resistance: inside a 114-country model
A new analysis models lower antibiotic consumption against resistance-related deaths. Its 10% scenario is a different measure from the UN mortality target, and it leaves access tradeoffs in view.
Policy & systems
TIME: measuring the hours cancer care takes
A structured chart-review tool measures documented encounter time, with internal validation in 46 prostate-cancer patients. International design input does not yet establish performance across health systems or the full patient time burden.
Policy & systems
Medical AI in Japan: familiarity and willingness are different questions
Two Japanese studies measure different forms of medical-AI acceptance. Their samples, autonomy definitions and survey designs explain why familiarity cannot be treated as a causal route to trust.
Policy & systems
7-1-7 outbreak targets: three clocks, different bottlenecks
The framework separates detection, notification and early-response milestones. Its practical value is locating delays and corrective actions, rather than declaring an epidemic controlled.
Policy & systems
Prior authorization APIs: three workflow steps are not three approvals
CMS’s rule distinguishes API functions and implementation guides. An Epic interview illustrates requirements discovery, documentation and request/response, while real-world information gaps and outcomes remain separate.
Policy & systems
CQC’s ADHD and autism assessment plans still need new rules
England plans to extend oversight to diagnosis-only services. Current CQC scope, proposed assessments regulation and separate payment reforms have different timelines.
Policy & systems
NHS Online: a virtual hospital still needs a physical care pathway
England’s Online NHS Trust plans to connect remote specialist care with local tests and procedures. Its handoffs matter as much as its app.
Policy & systems
After a phishing takedown, healthcare’s login problem remains
The Microsoft and Health-ISAC operation disrupted impersonation suppliers. Authentication and account recovery remain separate evidence questions.